跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CILOXAN ciprofloxacin 3mg/mL (as hydrochloride) ear drops - TGA Drug Approval Details
Approvals
/
TGA
/
CILOXAN ciprofloxacin 3mg/mL (as hydrochloride) ear drops
Approved
STANDARD
CILOXAN ciprofloxacin 3mg/mL (as hydrochloride) ear drops
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
4605bb9fa5bc5e4c
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
4605bb9fa5bc5e4c
Product Name
CILOXAN ciprofloxacin 3mg/mL (as hydrochloride) ear drops
Artg Id
121897
Artg Name
CILOXAN ciprofloxacin 3mg/mL (as hydrochloride) ear drops bottle
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2006-05-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/21d367b3802f2bcf297303ac6d1ae5d9.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/55a48b8d40f4fa1c7e98c79f42f3577f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
4605bb9fa5bc5e4c
Type
Standard
Back to TGA Approvals
